| 1 | NPFFR2, NPFFR1, NPVF, NPFF
|
| RF9, a potent and selective neuropeptide FF receptor antagonist, prevents opioid-induced tolerance associated with hyperalgesia.
|
| Simonin F, Schmitt M, Laulin JP, Laboureyras E, Jhamandas JH, MacTavish D, Matifas A, Mollereau C, Laurent P, Parmentier M, Kieffer BL, Bourguignon JJ, Simonnet G.
|
| Proc Natl Acad Sci U S A 103(2):466-71. Epub 2006 Jan 3. 2006
|
| 2 | NPFFR2, NPFF, NPFFR1
|
| Identification and characterization of two G protein-coupled receptors for neuropeptide FF.
|
| Bonini JA, Jones KA, Adham N, Forray C, Artymyshyn R, Durkin MM, Smith KE, Tamm JA, Boteju LW, Lakhlani PP, Raddatz R, Yao WJ, Ogozalek KL, Boyle N, Kouranova EV, Quan Y, Vaysse PJ, Wetzel JM, Branchek TA, Gerald C, Borowsky B.
|
| J Biol Chem 275(50):39324-31. 2000
|
| 3 | NPVF, NPFFR1
|
| New neuropeptides containing carboxy-terminal RFamide and their receptor in mammals.
|
| Hinuma S, Shintani Y, Fukusumi S, Iijima N, Matsumoto Y, Hosoya M, FujiiR, Watanabe T, Kikuchi K, Terao Y, Yano T, Yamamoto T, Kawamata Y, Habata Y,Asada M, Kitada C, Kurokawa T, Onda H, Nishimura O, Tanaka M, Ibata Y, Fujino M.
|
| Nat Cell Biol 2(10):703-8. 2000
|